4.7 Article

Barrier-to-Autointegration Factor 1 Protects against a Basal cGAS-STING Response

Journal

MBIO
Volume 11, Issue 2, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.00136-20

Keywords

interferon-stimulated gene; regulation; innate immunity; CRISPR; DNA virus; RNA virus; antiviral; interferon

Categories

Funding

  1. NIH [R01 AI127774, R01AI145296, R01AI45828, R01 AI134035, R01 CA193318, R01 CA227001, P01 CA092584]
  2. American Cancer Society Research Scholar Award

Ask authors/readers for more resources

Although the pathogen recognition receptor pathways that activate cell-intrinsic antiviral responses are well delineated, less is known about how the host regulates this response to prevent sustained signaling and possible immune-mediated damage. Using a genome-wide CRISPR-Cas9 screening approach to identify host factors that modulate interferon-stimulated gene (ISG) expression, we identified the DNA binding protein Barrier-to-autointegration factor 1 (Banf1), a previously described inhibitor of retrovirus integration, as a modulator of basal cell-intrinsic immunity. Ablation of Banf1 by gene editing resulted in chromatin activation near host defense genes with associated increased expression of ISGs, including Oas2, Rsad2 (viperin), Ifit1, and ISG15. The phenotype in Banf1-deficient cells occurred through a cGAS-, STING-, and IRF3-dependent signaling axis, was associated with reduced infection of RNA and DNA viruses, and was reversed in Banf1 complemented cells. Confocal microscopy and biochemical studies revealed that a loss of Banf1 expression resulted in higher level of cytosolic double-stranded DNA at baseline. Our study identifies an undescribed role for Banf1 in regulating the levels of cytoplasmic DNA and cGAS-dependent ISG homeostasis and suggests possible therapeutic directions for promoting or inhibiting cell-intrinsic innate immune responses. IMPORTANCE Although the interferon (IFN) signaling pathway is a key host mechanism to restrict infection of a diverse range of viral pathogens, its unrestrained activity either at baseline or in the context of an immune response can result in host cell damage and injury. Here, we used a genome-wide CRISPR-Cas9 screen and identified the DNA binding protein Barrier-to-autointegration factor 1 (Banf1) as a modulator of basal cell-intrinsic immunity. A loss of Banf1 expression resulted in higher level of cytosolic double-stranded DNA at baseline, which triggered IFN-stimulated gene expression via a cGAS-STING-IRF3 axis that did not require type I IFN or STAT1 signaling. Our experiments define a regulatory network in which Banf1 limits basal inflammation by preventing self DNA accumulation in the cytosol.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Gastroenterology & Hepatology

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice

David M. Alvarado, Juhee Son, Larissa B. Thackray, Gomez Castro Maria Florencia, Sarada Prasad, Xueyang Cui, Naomi M. Sonnek, Michael S. Diamond, Siyuan Ding, Matthew A. Ciorba

INFLAMMATORY BOWEL DISEASES (2022)

Article Cell Biology

A genome-wide CRISPR screen identifies HuR as a regulator of apoptosis induced by dsRNA and virus

Huixin Gao, Yuxia Lin, Changbai Huang, Xiaobo Li, Michael S. Diamond, Chao Liu, Rong Zhang, Ping Zhang

Summary: We performed a whole-genome CRISPR/Cas9 screen in A549 cells and identified potential regulators involved in cell death triggered by double-stranded RNA. Among the candidate genes, we found that the RNA-binding gene ELAV like protein 1 (HuR) plays a crucial role in apoptosis. We further showed that HuR regulates apoptosis by suppressing the translation of the antiapoptotic gene BCL2.

JOURNAL OF CELL SCIENCE (2022)

Article Virology

SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice

Emma S. Winkler, Rita E. Chen, Fahmida Alam, Soner Yildiz, James Brett Case, Melissa B. Uccellini, Michael J. Holtzman, Adolfo Garcia-Sastre, Michael Schotsaert, Michael S. Diamond

Summary: The study developed a mouse model for SARS-CoV-2 infection by introducing the human ACE2 gene into the mouse genome, providing insights into viral replication and pathology in mice. Additionally, the study identified the impact of the N501Y mutation in mice on viral replication and pathogenesis.

JOURNAL OF VIROLOGY (2022)

Article Biotechnology & Applied Microbiology

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants

Jason Z. Zhang, Hsien-Wei Yeh, Alexandra C. Walls, Basile I. M. Wicky, Kaitlin R. Sprouse, Laura A. VanBlargan, Rebecca Treger, Alfredo Quijano-Rubio, Minh N. Pham, John C. Kraft, Ian C. Haydon, Wei Yang, Michelle DeWitt, John E. Bowen, Cameron M. Chow, Lauren Carter, Rashmi Ravichandran, Mark H. Wener, Lance Stewart, David Veesler, Michael S. Diamond, Alexander L. Greninger, David M. Koelle, David Baker

Summary: We developed a protein biosensor that can rapidly and sensitively detect neutralizing antibodies against SARS-CoV-2 variants in serum. The biosensor can accurately differentiate between different samples based on the affinity and abundance of antibody binding, which is superior to traditional competition-based assays.

NATURE BIOTECHNOLOGY (2022)

Article Cell Biology

Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice

Andrew C. Hunt, James Brett Case, Young-Jun Park, Longxing Cao, Kejia Wu, Alexandra C. Walls, Zhuoming Liu, John E. Bowen, Hsien-Wei Yeh, Shally Saini, Louisa Helms, Yan Ting Zhao, Tien-Ying Hsiang, Tyler N. Starr, Inna Goreshnik, Lisa Kozodoy, Lauren Carter, Rashmi Ravichandran, Lydia B. Green, Wadim L. Matochko, Christy A. Thomson, Bastian Vogeli, Antje Kruger, Laura A. VanBlargan, Rita E. Chen, Baoling Ying, Adam L. Bailey, Natasha M. Kafai, Scott E. Boyken, Ajasja Ljubetic, Natasha Edman, George Ueda, Cameron M. Chow, Max Johnson, Amin Addetia, Mary-Jane Navarro, Nuttada Panpradist, Michael Gale, Benjamin S. Freedman, Jesse D. Bloom, Hannele Ruohola-Baker, Sean P. J. Whelan, Lance Stewart, Michael S. Diamond, David Veesler, Michael C. Jewett, David Baker

Summary: Researchers used a cell-free expression workflow to screen and optimize constructs containing computationally designed miniprotein inhibitors of SARS-CoV-2. They found that a homotrimeric version of the ACE2 mimic AHB2 (TRI2-2) achieved the broadest efficacy. The TRI2-2 miniprotein neutralized Omicron, Delta, and other variants with greater potency than clinically used monoclonal antibodies. It also provided prophylactic and therapeutic protection against SARS-CoV-2 in mice when administered intranasally. The designed miniprotein receptor mimics offer a widely applicable antiviral therapeutic strategy with advantages over antibodies and native receptor traps.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Microbiology

The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes

Maritza Puray-Chavez, Nakyung Lee, Kasyap Tenneti, Yiqing Wang, Hung R. Vuong, Yating Liu, Amjad Horani, Tao Huang, Sean P. Gunsten, James B. Case, Wei Yang, Michael S. Diamond, Steven L. Brody, Joseph Dougherty, Sebla B. Kutluay

Summary: SARS-CoV-2 utilizes various strategies to modulate host responses for efficient propagation. Ribosome profiling was used in this study to gain a deeper understanding of translationally regulated events in infected cells. The study found that viral mRNAs are not more efficiently translated than cellular mRNAs, despite their abundance. SARS-CoV-2 employs a highly efficient ribosomal frameshifting strategy and alternative translation initiation sites to increase the coding potential of its RNAs. In permissive cells, the virus represses the translation of several innate immune mediators. However, the impact of SARS-CoV-2 on host mRNA translation is more subtle in primary airway cell cultures, with marked upregulation of inflammatory and innate immune responses and downregulation of processes involved in ciliated cell function. These findings provide new insights into SARS-CoV-2's modulation of innate host responses and highlight unique mechanisms for therapeutic intervention.
Editorial Material Gastroenterology & Hepatology

Hepatology of flaviviruses

Adam L. Bailey, Michael S. Diamond

JOURNAL OF HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, Baoling Ying, Kai Wu, Chieh-Yu Liang, Hardik Jani, Philippa Martin, Nicholas J. Amato, Laura E. Avena, Daniela Montes Berrueta, Stephen D. Schmidt, Sijy O'Dell, Arshan Nasir, Gwo-Yu Chuang, Guillaume Stewart-Jones, Richard A. Koup, Nicole A. Doria-Rose, Andrea Carfi, Sayda M. Elbashir, Larissa B. Thackray, Darin K. Edwards, Michael S. Diamond

Summary: Bivalent vaccines induce broad immune responses against SARS-CoV-2 and its variants, offering a customizable approach to protect against COVID-19 as new strains emerge.

NATURE MEDICINE (2023)

Article Biochemistry & Molecular Biology

A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

Vikas Chonira, Young D. Kwon, Jason Gorman, James Brett Case, Zhiqiang Ke, Rudo Simeon, Ryan G. Cosner, Darcy R. Harris, Adam S. Olia, Tyler Stephens, Lawrence Shapiro, Michael F. Bender, Hannah Boyd, I-Ting Teng, Yaroslav Tsybovsky, Florian Krammer, Ningyan Zhang, Michael S. Diamond, Peter D. Kwong, Zhiqiang An, Zhilei Chen

Summary: We report the engineering and selection of two synthetic proteins, FSR16m and FSR22, for the potential treatment of SARS-CoV-2 infection. These proteins exhibit broad-spectrum neutralization of SARS-CoV-2 strains and show promising results in mice, reducing viral burden and weight loss.

NATURE CHEMICAL BIOLOGY (2023)

Review Microbiology

A molecular understanding of alphavirus entry and antibody protection

Arthur S. Kim, Michael S. Diamond

Summary: This Review provides an overview of the global epidemics caused by arthropod-transmitted RNA viruses known as alphaviruses. It highlights the host factors required for alphavirus entry, the mechanisms by which protective antibodies inhibit alphavirus infection, and the progress of clinical evaluation of candidate vaccines focusing on humoral immunity.

NATURE REVIEWS MICROBIOLOGY (2023)

Editorial Material Microbiology

Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters

Adrianus C. M. Boon, Tamarand L. Darling, Peter J. Halfmann, John Franks, Richard J. Webby, Dan H. Barouch, Julia R. Port, Vincent J. Munster, Michael S. Diamond, Yoshihiro Kawaoka

PLOS PATHOGENS (2022)

Article Immunology

SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients

Frank J. Lin, Alexa Michelle Altman Doss, Hannah G. Davis-Adams, Lucas J. Adams, Christopher H. Hanson, Laura A. VanBlargan, Chieh-Yu Liang, Rita E. Chen, Jennifer Marie Monroy, H. James Wedner, Anthony Kulczycki, Tarisa L. Mantia, Caitlin C. O'Shaughnessy, Saravanan Raju, Fang R. Zhao, Elise Rizzi, Christopher J. Rigell, Tiffany Biason Dy, Andrew L. Kau, Zhen Ren, Jackson S. Turner, Jane A. O'Halloran, Rachel M. Presti, Daved H. Fremont, Peggy L. Kendall, Ali H. Ellebedy, Philip A. Mudd, Michael S. Diamond, Ofer Zimmerman, Brian J. Laidlaw

Summary: The study found that most immunocompromised individuals can generate memory B and T cell responses after receiving SARS-CoV-2 vaccines. However, some individuals with immunodeficiency had deficiencies in certain immune responses after the primary vaccination, which could be restored by booster doses. Booster vaccination also enhanced the SARS-CoV-2-specific B and T cell responses and induced Omicron-specific memory B cells in immunocompromised individuals who had not been previously exposed to COVID-19.

FRONTIERS IN IMMUNOLOGY (2022)

Article Cell Biology

Zika virus spreads through infection of lymph node-resident macrophages

Glennys Reynoso, David N. Gordon, Anurag Kalia, Cynthia C. Aguilar, Courtney S. Malo, Maya Aleshnick, Kimberly A. Dowd, Christian R. Cherry, John P. Shannon, Sophia M. Vrba, Autumn C. Holmes, Yael Alippe, Sonia Maciejewski, Kenichi Asano, Michael S. Diamond, Theodore C. Pierson, Heather D. Hickman

Summary: To understand the initial steps in Zika virus (ZIKV) transmission, researchers investigated the virus's movement from the skin to the lymph nodes. Contrary to previous beliefs, migratory immune cells were not necessary for the virus to reach the lymph nodes or the bloodstream. Instead, a specific subset of macrophages in the lymph nodes, called CD169+ macrophages, were found to be rapidly infected by ZIKV and release the virus to infect other lymph nodes. These findings improve our understanding of ZIKV dissemination and identify a potential target for antiviral intervention.

CELL REPORTS (2023)

Article Microbiology

Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2

Samantha R. Mackin, Pritesh Desai, Bradley M. Whitener, Courtney E. Karl, Meizi Liu, Ralph S. Baric, Darin K. Edwards, Taras M. Chicz, Ryan P. McNamara, Galit Alter, Michael S. Diamond

Summary: Fc-Fc gamma receptor interactions and alveolar macrophages play a crucial role in controlling infection with SARS-CoV-2 variants in mice vaccinated with ancestral vaccines. While the spike protein antigenic changes in SARS-CoV-2 variants reduce the neutralizing efficiency of legacy vaccine-induced antibodies, vaccines like mRNA-1273 and BNT162b2 still protect against severe disease and death, indicating the involvement of other aspects of immunity in controlling lung infection. Antibodies elicited by vaccines can bind Fc gamma receptors and exert effector functions against SARS-CoV-2 variants, and this property is associated with improved clinical outcomes. However, the causal relationship between Fc effector functions and vaccine-induced protection against infection needs further investigation.

NATURE MICROBIOLOGY (2023)

Meeting Abstract Immunology

Ablation of cDC2 Lineage specification by mutations within the-165 kb zeb2 enhancer

Tiantian Liu, Sunkyung Kim, Pritesh Desai, Do-Hyun Kim, Xiao Huang, Stephen T. Ferris, Renee Wu, Feiya Ou, Takeshi Egawa, Steven J. Van Dyken, Michael S. Diamond, Masato Kubo, Theresa L. Murphy, Kenneth M. Murphy

JOURNAL OF IMMUNOLOGY (2022)

No Data Available